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PMS4
APPlying Weighted CuMulAtive exPoSure ModelS to PAtternS of 
nonSPeCifiC SyMPtoM ConSultAtionS for eArly diAgnoSiS: A PriMAry 
CAre dAtAbASe Study of Knee PAin And oSteoArthritiS
Yu D1, Peat G1, Bedson J1, Edwards J1, Turkiewicz T2, Jordan K1
1Keele University, Staffordshire, UK, 2Lund University, Lund, Sweden
Objectives: To develop and validate predictive models for estimating risk of early 
diagnosis of knee osteoarthritis (OA) by weighted cumulative exposure (WCE) 
function scores of prior knee pain consultations. MethOds: Both derivation and 
validation datasets were from an electronic healthcare record (EHR) database 
(Consultations in Primary Care Archive [CiPCA]) in England. WCE functions for 
modelling cumulative effect of time-varying knee pain consultations weighted by 
recency was derived as predictive tool in a population based case-control sample 
and validated in a prospective cohort sample. Two sets of WCE function scores: 
WCE (Half-Normal) score and WCE (Spline) score were evaluated and compared 
on model fitness, discrimination, and calibration both in derivation and validation 
phases. Results: People with the most recent and the most frequent knee pain 
consultations were more likely to have high WCE scores (both sets) and these were 
associated with increased risk of knee OA diagnosis both in derivation and valida-
tion phases. Better model fit, discrimination, and calibration were observed for 
models with WCE (Spline). cOnclusiOns: WCE functions can be used to model 
pre-diagnostic symptoms within routine EHR data and may provide novel low-cost 
predictive tools that may contribute to early diagnosis.
PMS5
CliniCAl effeCtiveneSS of biSPhoSPhonAteS for Prevention  
of frAgility frACtureS: A SySteMAtiC revieW And netWorK  
MetA-AnAlySiS
Sanderson J
University of Sheffield, Sheffield, UK
Objectives: To assess the relative efficacy of bisphosphonates (alendronate, risedro-
nate, ibandronate and zoledronate) for the treatment of Osteoporosis using network 
meta-analysis (NMA). MethOds: A systematic review of the literature was conducted 
using PRISMA guidelines. A network meta-analysis was used to determine the relative 
efficacy of treatments on four fracture outcomes (vertebral, non-vertebral, hip and 
wrist) and percentage change in femoral neck bone mineral density (BMD). Treatment 
effects were modelled using an exchangeable treatment effects model. Heterogeneity 
in treatment effects was explored by considering potential treatment effect modifiers 
using meta-regression. Where appropriate, inconsistency between direct and indirect 
evidence was assessed using node-splitting. Results: 46 randomised controlled tri-
als (RCTs) were identified. Twenty seven RCTs provided fracture data and 35 RCTs 
provided BMD data for analysis. Zoledronate was associated with the greatest treat-
ment effect on vertebral fractures (HR 0.41, 95% CrI 0.28-0.56) and percentage change 
in BMD (3.21, 95% CrI 2.52-3.86) compared to Placebo. The greatest treatment effect on 
non-vertebral and wrist fractures was given by risedronate (HR 0.72, 95% CrI 0.53-0.89 
and HR 0.77, 95% CrI 0.44-1.24, respectively). For hip fractures the greatest treatment 
effect was given by alendronate (HR 0.78, 95% CrI 0.44-1.30). cOnclusiOns: All treat-
ments were associated with beneficial effects on fractures and femoral neck BMD 
relative to placebo. For vertebral fractures and percentage change in BMD the treat-
ment effects were statistically significant for all treatments. Pairwise comparisons 
between treatments indicated that no active treatment was statistically significantly 
more effective than any other active treatment for fracture outcomes. There was some 
heterogeneity in treatment effects between studies suggesting differential treatment 
effects according to study characteristics However, there was no evidence of differ-
ential treatment effects with respect to gender and age.
PMS6
CoMPliAnCe With AlloPurinol AMong hyPertenSive PAtientS With 
gout diAgnoSiS And the relAtionShiP to onSet of end-StAge renAl 
diSeASe
Perreault S1, Nuevo J2, Baumgartner S3, Morlock R3
1Université de Montréal, Montreal, QC, Canada, 2Astrazeneca, Madrid, Spain, 3Ardea Biosciences, 
San Diego, CA, USA
Objectives: Risk of end-stage renal disease (ESRD) in both hypertension and 
gout has been examined in the literature. However, the impact of allopurinol 
adherence on primary prevention of ESRD has not been assessed. The objective is 
to evaluate impact of better allopurinol adherence on ESRD onset. MethOds: A 
cohort of 2752 patients with gout diagnosis was reconstructed using the Québec 
RAMQ and MED-ECHO administrative databases. New users of allopurinol, aged 
45-85 years, with a diagnosis of hypertension and treated with an antihypertensive 
drug between 1997-2007 were eligible. A nested case-control design was used to 
study ESRD occurrence. Every ESRD case was matched for age, sex and duration 
of follow-up for up to 15 controls. Adherence level was assessed as medication 
possession ratio. Conditional logistic regression models were used to estimate rate 
ratios (RR) of ESRD adjusting for covariables. Results: Patients had a mean age 
of 68 years, 82% were men, approximately 50% had ≥ 1 cardiovascular disorder, 
33% had dyslipidemia, 21% had diabetes, 15% had chronic kidney disease, and 
21%, 33%, and 42% were taking thiazides, low-dose aspirin, and NSAIDs, respec-
tively. Clinical characteristics were similar among allopurinol adherent versus 
non-adherent patients. Major risk factor for ESRD onset was chronic kidney dis-
ease at stages 1-3 (RR: 8.00; CI: 3.16 -22.3), and hypertension severity (≥ 3 vs. < 3 
antihypertensive treatments) was a trending risk factor as a crude estimate (RR: 
1.94; CI: 0.68-5.51). Of 341 patients (cases, n= 22; controls, n= 319), high adherence 
(≥ 80%) to allopurinol, versus lower adherence (< 80%), was associated with a lower 
rate of ESRD onset (RR: 0.35; confidence interval [CI]: 0.13-0.91). cOnclusiOns: 
This population-based study suggests that better allopurinol adherence may be 
associated with risk reduction of new-onset ESRD in hypertensive patients. Further 
research is needed, as this study was limited by the small number of cases and 
potential residual confounding factors.
MuSCulAr-SKeletAl diSorderS – Clinical outcomes Studies
PMS1
the effeCt of PoSitioning the loWer extreMitieS on PoStoPerAtive 
bleeding After totAl Knee rePlACeMent
Gombos G1, Borsos Z1, Sió E1, Bajsz V1, Steinhausz V1, Szabó J1, Boncz I2, Schmidt B1
1University of Pécs, Zalaegerszeg, Hungary, 2University of Pécs, Pécs, Hungary
Objectives: Postoperative blood-saving is high-priority after every planned surgery. 
The aim of this study was to analyse the effect of positioning of lower extremities on 
the postoperative bleeding after total knee replacement surgery. MethOds: Sixty 
patients from the orthopaedic department of Zala County Hospital who were operated 
on for insertion of a unilateral total knee prosthesis with cement and got autologous 
blood transfusion (age 35-80 years), were randomly assigned to three intervention 
groups. In Group I (n= 20), patients were in normal laying position, in Group II (n= 20), 
hips were positioned in flexion and knee in extension and in Group III (n= 20), hips and 
knees were positioned in 30o flexion in the first 6 postoperative hours. The surgical 
technique, the surgeon and the anticoagulant treatments were the same. Data col-
lection: medical records, haemoglobin and haematocrit. For the clinical parameters, 
t-tests, ANOVA and Scheffe post hoc tests were used. Statistical significance was estab-
lished at the α -level of 0.05, and IBM SPSS 20.0v was used. Results: During the first 
six postoperative hours positioning not affected significantly on the volume of bleed-
ing and recirculated blood volume (Group I: 615.0±247.3, Group II: 600.0±358.2, Group 
III: 715.0±392.3 ml, ANOVA: p= 0.714; post hoc: p1-2= 0.995, p1-3= 0.805, p 2-3= 0.751), 
either in hours 6-72 (Group I: 775.0±227.6, Group II: 762.0±332.8, Group III: 960.0±400.6 
ml, p= 0.335; p1-2= 0.996, p1-3= 0.462, p2-3= 0.414). Most units of homologous transfu-
sion were needed in Group II (10 units). Position had not effect on the intensity of pain 
and value of the active range of motion of the knee (p= 0.682 vs. p = 0.585) either in 
haemoglobin and haematocrit values (p= 0.362 vs. p= 0.559). cOnclusiOns: These 
results of the present study suggest that the postoperative positioning of the lower 
extremities after knee replacement not affected the postoperative bleeding, the pain 
and the range of motion of the knee joint.
PMS2
rheuMAtoid ArthritiS And iSCheMiC heArt diSeASe in PAtientS froM 
bluMenAu - brAzil
Nobre M1, Gomes R2
1Heart Institute (InCor) São Paulo University, São Paulo, Brazil, 2FURB - University of Blumenau, 
São Paulo, Brazil
Objectives: Patients with rheumatoid arthritis (RA) have a higher risk of ischemic 
cardiac events compared with the general population. This would be explained 
not only by the greater presence of traditional risk factors, but also by the sys-
temic inflammatory nature of arthritis. To compare the prevalence of ischemic 
heart disease (IHD) in a target RA population with the international prevalence 
data. MethOds: Cross-sectional study including 183 adult patients with code M05-
M06 (ICD-10) attended in primary or secondary care units from Blumenau city, 
southern Brazil, in 2014. Data collection was performed through structured personal 
interview and, if necessary, later by phone. The presence of IHD was defined as 
acute myocardial infarction, unstable angina, percutaneous coronary intervention or 
coronary artery bypass graft that have occurred after the diagnosis of RA. Results: 
153/183 patients were female (83.6%), mean age of 56.9 years and disease mean 
duration of 12.1 years. The number of cases with first acute myocardial infarction, 
unstable angina or myocardial revascularization after the diagnosis of rheumatoid 
arthritis was 7 (3.8%), two men and five women, two of those fatal, one of each sex. 
When the international prevalence are in Denmark 2.6%, Sweden 3.3%, Netherlands 
3.8%, UK 4.8%, France 4.1%, Canada 3.5%, US 3.7%, China 3.5%, Russia 5.1%, New 
Zealand 5.2%. cOnclusiOns: The result shows that the prevalence of coronary 
ischemia in patients with rheumatoid arthritis from Blumenau is similar to the 
prevalence observed in other countries.
PMS3
inCreASed riSK of oSteoPoroSiS in dePreSSed PAtientS: A reAl World 
dAtA Study ConduCted in itAly
Heiman F, Moretti R, Pegoraro V, Cataldo N
IMS Health Information Solutions Medical Research S.r.l, Milan, Italy
Objectives: Depression is a chronic debilitating disease with high prevalence that 
considerably affects quality of life. The relationship between depression and osteo-
porosis has been demonstrated, but the evidence is heterogeneous. The aim of the 
present study is to investigate about this relationship in the Italian primary care set-
ting. MethOds: This was a retrospective analysis based on data extracted from Italian 
IMS Health Longitudinal Patient Database. Two cohorts have been defined: patients 
with a diagnosis of Depression (Index Date) during the period January 2004 - December 
2010 and without neither Depression neither Osteoporosis diagnosis during the 5 years 
period preceeding the Index Date; patients with a first contact (Index Date) during the 
period January 2004 - December 2010 that are not in the previous cohort (free from 
Depression) and without neither Osteoporosis neither Depression diagnosis during 
the five years period preceeding the Index Date. Patients in both the two cohorts have 
been followed-up until one of the following event occurred first: Osteoporosis diagnosis 
registration, death, end of registration with the GP, 31 December 2013. Osteoporosis 
incidence rates have been separately calculated in the two cohorts and Osteoporosis 
cumulative incidence curves have been estimated using Kaplan Meier methods and 
compared performing log rank tests. Both univariate and multivariate Cox proportional 
hazard models were performed. Results: Osteoporosis incidence was higher in the 
cohort of depressed patients (2.33 cases per 100 person years vs 1.22 cases per 100 
person years) and results were confirmed by the log rank test (p< 0.001). Increased 
risk of developing osteoporosis for depressed patients was shown both by univariate 
proportional hazard model (HR= 1.75, CI= [1.72,1.78]) and multivariate proportional 
hazard model (HR= 1.15, CI= [1.13, 1.17]). cOnclusiOns: Results from this study sug-
gests that the relationship between Depression and Osteoporosis is confirmed also 
in the primary care setting in Italy.
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PMS10
effiCACy of SurgiCAl vS. non-SurgiCAl treAtMent of CArPAl tunnel 
SyndroMe (CtS): A SySteMAtiC revieW
Goyal R, Kaneria J, Rai MK, Bhutani MK, Singh R, Rana P
Tata Consultancy Services, Mumbai, India
Objectives: To conduct a systematic review to compare the efficacy of surgical 
versus non-surgical treatment of carpal tunnel syndrome (CTS). MethOds: We 
searched Embase, Medline & Cochrane databases from January 2000 to June 2015 
and included all randomised controlled trials comparing any surgical versus non-
surgical therapies in patients with CTS. Two authors independently assessed the 
eligibility of the trials and performed all the necessary steps of a systematic review. 
A qualitative analysis of the results was done. Results: From the 112 studies 
retrieved, five studies reached the stage of data extraction. Three studies compared 
decompressive surgery with local steroid injection, one study compared surgical 
versus non-surgical (hand therapy and ultrasound) and the last study compared 
surgery versus splinting, respectively. The studies included 95 wrists, 163 wrists, 50 
patients, 116 patients and 176 patients. The study with 50 patients reported that at 
20 weeks patients who underwent surgery had greater symptomatic improvement 
than those who were injected with steroids. The mean improvement in GSS after 20 
weeks was 24.2 (SD 11.0) in the surgery group vs 8.7 (SD 13.0) in the injection group 
(p < 0.001). Similarly, the other two trials comparing surgery with steroid injection 
reported that surgery has additional benefits in improving CTS. The trial comparing 
surgery with splinting reported a success rate of 90% with surgery as compared to 
75% with splinting. The trial with surgery versus non-surgery revealed a signifi-
cant 12-month adjusted advantage for surgery in function (CTSAQ function score: 
Delta -0.40, 95% CI 0.11-0.70, p= 0.0081) and symptoms (CTSAQ symptom score: 0.34, 
0.02-0.65, p= 0.0357). cOnclusiOns: Surgical treatment of CTS relieves symptoms 
significantly better compared to non-surgical treatment. Further, the surgical treat-
ment was a better option as compared to local steroid injections and splinting.
PMS11
uSing ACtive teChniqueS to hAndle ChroniC loW bACK PAin CAuSed by 
SedentAry WorK
Gombos G1, Vizsy M1, Sió E1, Bajsz V1, Steinhausz V1, Szabó J1, Boncz I2, Schmidt B1
1University of Pécs, Zalaegerszeg, Hungary, 2University of Pécs, Pécs, Hungary
Objectives: Chronic low back pain (cLBP) is a key issue for health care and society. 
The purpose of this study was to evaluate the efficacy of a 3-months long training 
programme by examining the muscular strength, the range of motion, the muscle-
stretching, the pain and the functional development at sedentary workers with 
cLBP. MethOds: The examination was carried out in Zalaegerszeg in 2014. Thirty 
patients were involved (30-60y) who had cLBP because of sedentary work for many 
years. The participants received core stability training and traditional active and 
passive stretching exercises integrated with myofascial release technique. Data 
collection: 1) core strength and stability tests (DAVID 110,130 and modified plank-
tests), 2) lumbar spine range of motion (Zebris-system), 3) muscle stretching (David-
conception), 4) pain and functionality (Visual Analog Scale, Roland-Morris Scale) 
and 5) general health status (physical examination, discharge report, self-made 
questionnaire). Descriptive statistics, t-test and chi2–test were used (IBM SPSS 
19v.). Results: The trunk muscle forces (flexors p= 0.003, extensors p= 0.008) and 
the modified plank tests (prone and side position p= 0.001, supine position p= 0.042) 
shown significant improvement. The spine range of motion shown significant 
improvements (p= 0.001). The level of pain decreased significantly (p= 0.001), simi-
lar to the Roland-Morris Index (p= 0.001). The muscle stretching tests represented 
important but not significant changes. cOnclusiOns: Present study provides 
further evidence of the effectiveness of core stabilisation and muscle stretching 
techniques in cLBP. It would be worthwhile to continue this study involving more 
patients with long follow-up emphasizing the myofascial release techniques.
PMS12
effeCtiveneSS of AlloPurinol in AChieving And SuStAining tArget 
SeruM urAte: An AnAlySiS of A nAtionAl integrAted u.S. heAlthCAre 
SySteM
Singh Ja, Yang S
UAB SCHOOL OF MEDICINE, Birmingham, AL, USA
Objectives: To comprehensively assess as to which patient, comorbidity, physi-
cian, system, health care access and disease factors are associated with the abil-
ity to achieve and maintain target serum urate (sUA) with allopurinol in patients 
with gout. MethOds: We used National VA national databases from 2002-2012. 
Patients were eligible if they had ≥ 2 outpatient or ≥ 1 inpatient encounters with 
an International Classification of Diseases-ninth version (ICD-9) code 274.xx for 
gout, and met 12-month observability rule. Index allopurinol use was defined as 
the filling of a new allopurinol prescription with no allopurinol exposure in the 
previous 121 days. Treatment successes were defined as the achievement of: (1) post-
index sUA < 6 mg/dl; and (2) post-index sUA < 6 mg/dl that was sustained. Results: 
41,153 unique patients with 47,072 episodes contributed to analyses of achieving 
target sUA (success 1) and 17,402 unique patients with 18,323 episodes to achiev-
ing and maintaining target sUA (success 2). In multivariable-adjusted models, the 
following were associated with significantly higher odds of both successes 1 and 
2: older age, normal BMI (18.5-25 kg/m2), currently married, Deyo-Charlson index 
score of 0, main provider being a physician, rheumatologist as the main provider 
rather than non-rheumatologist, Midwest location for the health care facility, a 
lower hospital bed size, service-connection conditions of 50% or more, longer dis-
tance to the nearest VA facility, lower pre-index sUA, higher allopurinol start and 
end dose, higher allopurinol adherence and recommended or fast allopurinol dose 
escalation. cOnclusiOns: In this study, we identified several important factors 
associated with achieving and maintaining sUA < 6 mg/dl. This new knowledge 
provides several new potential modifiable targets for improving the ability to lower 
serum urate with allopurinol pharmacotherapy and sustain a therapeutic target in 
patients with gout.
PMS7
reduCtion in C-reACtive Protein With biologiC drugS in rheuMAtoid 
ArthritiS And SPondylitiS PAtientS in gerMAn rheuMAtologiSt 
PrACtiCeS
Gossen N, Kostev K
IMS Health, Frankfurt am Main, Germany
Objectives: C-reactive protein (CRP) is one of the markers of inflammation 
in the body and a predictor of treatment outcome in patients with rheumatoid 
arthritis (RA) treated with biologic drugs. CRP levels > 10 mg/L are associated 
with very high cardiovascular risk. The aim of this study was to evaluate the 
difference in mean CRP levels before and after the initiation of biologic drugs in 
German rheumatologist practices. MethOds: German Disease Analyzer database 
including 34 rheumatologist practices was used. Data from 1,695 patients (mean 
age 52.1 years, 62% female) with a diagnosis of either rheumatoid arthritis (RA, 
ICD 10: M05, M06) or spondylitis (SP, ICD 10: M45, M46) with an initial biologic 
drug (etanercept, infliximab, adalimumab, golimumab) prescription (index date) 
between January 2004 and December 2013 and documented CRP levels within 
one year pre-index and one year post-index were identified and descriptively 
analyzed. Results: After the beginning of biologic drug therapy, CRP levels sig-
nificantly decreased from a mean of 17.7 mg/L before the index date to 11.7 mg/L 
after the index date (33.9% reduction, P< 0.001). In male patients, the relative 
difference in CRP levels was significantly higher than in female patients (39.0% 
versus 29.8%). The relative difference decreased with an age (49.5% in the age 
group < = 40 years, 31.4% in age group 41-50, 31.8 in age group 51-60 and 25.9 in 
age group > 60). cOnclusiOns: In this retrospective database study, performed 
among 1,695 patients with rheumatoid arthritis or spondylitis, we observed sig-
nificant reductions in CRP levels associated with male gender and younger age. 
These data have clinical relevance and significantly extend prior observational 
studies.
PMS8
CliniCAl evAluAtion of AMritAdi guggulu And MAndoorA bhASMA in 
oSteoArthritiS PAtientS
Acharya S1, Singh R1, Nagappa AN2, Mateti UV2
1PG Dept. of Kayachikitsa, Muniyal Institute of Ayurveda Medical Sciences, Manipal, India, 2Dept. 
of Pharmacy Management, MCOPS, Manipal University, Manipal, India
Objectives: To compare the combined effect of Amritadi Guggulu and Mandoora 
Bhasma with Trayodashanga Guggulu in Osteoarthritis patients. MethOds: A ran-
domized single blind clinical study with pre-test and post-test design was adopted 
where the patients were given treatment for a period of one month with follow-up. 
The inclusion criterion of the patients includes Osteoarthritis of knee joints, age 
group between 30 - 60 years, either gender, and irrespective of occupation and 
habitat. A total 307 patients of osteoarthritis of knee joint were selected from 
out-patient and inpatient departments of Muniyal Ayurveda Hospital, Manipal 
and grouped into A and B 154 and 153. Group A is given Amritadi Guggulu and 
Mandoora Bhasma and Group B is given Trayodashanga Guggulu. There were 4 
dropouts in group A and 3 in group B. The outcomes were assessed by using paired 
t-test and p< 0.05 was considered as statistically significant. Results: There was 
significant relief in Joint pain (83.74%), Joint tenderness (80.33%), Joint stiffness 
(82.83%), Swelling (63.39%), Crepitus (42.26%) and restriction of movement (74.50%) 
which was statistically significant (p< 0.001 ) in group A treated with Amritadi 
Guggulu and Mandoora Bhasma. In group B treated with Trayodashanga Guggulu 
was also observed relief in in Joint pain (47.80%), Joint tenderness (78.33%), Joint 
stiffness (61.61%), Swelling (64.28%), and Crepitus (41.86%) restriction of move-
ment (60.46%) which was statistically significant (p< 0.001). In group A there was 
statistically significant improvement in TLC (15.82%), Hemoglobin (11.58%) and 
ESR (47.71%) after treatment. In group B also observed statistically significant 
improvement in TLC (14.52%), Hemoglobin (6.01%) and ESR (43.69%) after treat-
ment. cOnclusiOns: Ayurveda management with administration of Amritadi 
Guggulu and Mandoora Bhasma showed good results when compared with 
patients treated with Trayodashanga Guggulu only. There was an increase in Hb% 
and decrease in ESR in these patients.
PMS9
the effeCt of Szigetvár therMAl WAter on quAlity of life of 
PAtientS With rheuMAtiC diSeASeS
Hanzel A1, Molics B1, Juhász K2, Boncz I1, Ágoston I1, Varga C1
1University of Pécs, Pécs, Hungary, 2National Health Insurance Fund Administration, Pécs, 
Hungary
Objectives: The thermal water of the City of Szigetvár, discovered in 1966, has a 
temperature of 62 oC when it reaches the surface and contains alkali-bicarbonatec 
with sodium chloride. The main objective is to explore the potential improvement in 
the quality of life and the effect of the thermal water as compared to warm tap water 
(placebo). It is assumed that the water with organic material content has a therapeuti-
cal effect. MethOds: Our research focuses on the therapeutic effect of this thermal 
water on patients suffering from rheumatic diseases, especially cox- and gonarthrosis, 
in a double–blind study. Sample size was n= 75. The treatment of 5 days /patient is per-
formed in Szigetvár spa in two randomly selected groups, using two tubs, and lasting 
30 minutes each time. Every patient is given tangentor and bath tub treatment alto-
gether 15 times. The methods used for the collection of data include the VAS, physical 
examination, document analysis and the Western Ontario and McMaster Universities 
Arthritis Index (WOMAC). Data were processed with the Microsoft Office Excel 2003 
and Windows SPSS 20.0 softwares, and the results were tested with the Mann-Whitney, 
the Wilcoxon and the khi-square tests. Results: Our data have shown a significant 
improvement (p= 0.035) in knee extension in the group treated with thermal water in 
contrast with the group treated with tap-water. The difference in life qualities was also 
significant measured by a Likert scale (p= 0.014). cOnclusiOns: The thermal water 
of the City of Szigetvár significantly improved the health status of patients suffering 
from rheumatic diseases in knee extension.
